Newsfeeds Archive - Page 3 of 8

1 minute read

Minerva Neurosciences Announces FDA Acceptance Of The Filing Of The NDA For Roluperidone For The Treatment Of Negative Symptoms In Schizophrenia

May 10, 8:10 AM

FDA confirms acceptance of the filing of the NDA for roluperidone Application has been granted a standard review FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of February 26,

NERV

3 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

May 1, 1:31 PM

Gainers Minerva Neurosciences (NASDAQ:NERV) shares rose 52.1% to $4.26 during Monday’s regular session. Trading volume for Minerva Neurosciences’s…

APLT

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

April 26, 1:31 PM

Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 45.3% to $2.14 during Wednesday’s regular session. As of 13:30 EST,…

APLM

3 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

April 11, 1:31 PM

Gainers Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 146.6% to $3.6 during Tuesday’s regular session. Innovative Eyewear’s stock…

AKAN

1 minute read

Minerva Neurosciences Q4 EPS $(1.26) Misses $(0.92) Estimate, Cash, Cash Equivalents, And Restricted Cash Of $36.2M

By Benzinga Newsdesk

March 8, 8:37 AM

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $(0.92) by 36.96 percent. This is a 68.5 percent increase over losses of $(4.00) per share

NERV

6 minute read

Earnings

Earnings Scheduled For March 8, 2023

By Benzinga Insights

March 8, 5:42 AM

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.

ABM

1 minute read

Minerva Neurosciences Has Been Granted Canadian Patent Number 3117855 Titled “Methods Of Use Of Cyclic Amide Derivatives To Treat Schizophrenia”

By Benzinga Newsdesk

January 10, 1:53 PM

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3117855/summary.html

EWC

2 minute read

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch

By Chris Katje

December 29, 5:51 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming.

GRRR

2 minute read

Tesla, Amazon, Minerva, Kala Pharma, Gorilla Tech: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

December 28, 9:32 PM

Major Wall Street indices closed in the red on Wednesday as investors and traders lost optimism regarding any possible year-end rebound and braced themselves for the new year while lightening up on positions ahead of the end of the week.

AMZN

2 minute read

Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher

By Lisa Levin

December 28, 3:32 PM

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.

GRRR